Coronavirus research news archive

Research News

2024

• Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021
  Emerging Infectious Diseases, April 2024
• How lung distress from SARS-CoV-2 can cause heart damage
  NIH Research Matters, April 2, 2024
  
• Severe lung infection during COVID-19 can cause damage to the heart
  NHLBI news, March 20, 2024
• SARS-CoV-2 fragments may cause problems after infectionNIH Research Matters, February 27, 2024 
  
• COVID-19 vaccination and boosting during pregnancy protects infants for six months
  NIH/NIAID news, February 14, 2024
  
• Rapid dynamic changes of FL.2 variant: A case report of COVID-19 breakthrough infection, co-authored by Fogarty grant recipients Roger Shapiro, Joseph Makhema, and Shahin Lockman, and trainees Sikhulile Moyo, Gobuiwang Khilly Kurusa (Gasenna), and Simani Gaseitsiwe
  International Journal of Infectious Diseases, January 2024

2023

• The evolution and interpretation of seroprevalence of SARS-CoV-2 antibodies among South African blood donors from the Beta to Omicron variant-driven waves, co-authored by Fogarty trainees Marion Vermeulen, Wendy Sykes, Charl Coleman, Tanya Nadia Glatt, and Karin van den Berg
  Vox Sanguinis, December 29, 2023
• What We Learned from Covid Response
  NIH Record, December 8, 2023
• Examining the impact of COVID-19 on mortality in the U.S.
  Global Health Matters, November/December 2023
• Studying COVID-19 in South Africa sheds light on how immunity contributes to variant success
  Global Health Matters, November/December 2023
• Utilizing river and wastewater as a SARS-CoV-2 surveillance tool in settings with limited formal sewage systems, co-authored by Fogarty International Research Scientist Kayla G. Barnes
  Nature Communications, November 30, 2023
• Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty, co-authored by Fogarty’s Cécile Viboud
  Nature Communications, November 20, 2023
• A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection, co-authored by Fogarty’s Nídia Trovão
  European Journal of Human Genetics, November 8, 2023
• Study reveals how young children's immune systems tame SARS-CoV-2
  NIH/NIAID news, October 13, 2023
  
• Evolutionary and spatiotemporal analyses reveal multiple introductions and cryptic transmission of SARS-CoV-2 VOC/VOI in Malta, co-authored by Fogarty's Nídia S. Trovão
  Microbiology Spectrum, October 6, 2023
  
• Ohio State Scientists Evaluate Role of Deer in SARS-CoV-2 Transmission
  NIAID blog, August 28, 2023
• SARS-CoV-2 can cause lasting damage to cells’ energy production
  NIH Research Matters, August 22, 2023
• COVID-19 vaccination and boosting during pregnancy benefits pregnant people and newborns
  NIH/NIAID news, August 11, 2023
• Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts, co-authored by Fogarty’s Nídia S. Trovão
  Science Translational Medicine, August 9, 2023
• Genetic variant associated with absence of COVID-19 symptoms
  NIH Research Matters, August 8, 2023
• Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave, co-authored by Fogarty’s  Nídia S. Trovão, David Spiro, and Zeba Rasmussen
  BMC Genomics, August 3, 2023
  
• Clinical Presentation and Outcome of Acute Respiratory Illnesses in South African Children During the COVID-19 Pandemic, co-authored by Emerging Global Leader Marieke Van Der Zalm
  The Pediatric Infectious Disease Journal, August 2023
• NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
  HHS/NIH news, July 31, 2023
• Project NextGen — Defeating SARS-CoV-2 and Preparing for the Next Pandemic, authored by HHS Secretary Xavier Becerra and White House COVID-19 Response Coordinator Ashish Jha
  New England Journal of Medicine, July 26, 2023
• Research in Context: Progress toward universal vaccines
  NIH Research Matters, July 25, 2023
• Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica, co-authored by Fogarty’s Kaiyuan Sun
  Communications Medicine, July 22, 2023
• SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: a case-control study, co-authored by Fogarty Emerging Global Leader Marieke M. Van Der Zalm
  BMC Infectious Diseases, June 29, 2023
• Designing a SARS-CoV-2 decoy
  NIH Catalyst, June 13, 2023
• NIH study identifies features of Long COVID neurological symptoms
  NIH/NINDS news, May 5, 2023
• Biomarker pattern found in kids with COVID 19-linked inflammatory syndrome
  NIH/NICHD news, April 25, 2023
• SARS-CoV-2 infection weakens immune-cell response to vaccination
  NIH/NIAID news March 20, 2023
• Inhalable hydrogel protects lungs from SARS-CoV-2
  NIH Research Matters, March 7, 2023
• Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022, co-authored by Fogarty's Cécile Viboud
  elife, Feburary 22, 2023
• The NIH-led research response to COVID-19
  Science, February 2, 2023
• Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa, co-authored by Fogarty’s Kaiyuan Sun & Cécile Viboud
  Nature Communications, January 16, 2023
• Developing mucosal vaccines for respiratory viruses
  NIH/NIAID news, January 11, 2023
• Paxlovid reduces serious risks from Omicron variants
  NIH Research Matters, January 10, 2023

2022

• CDC and Global Health Systems and Programs During the COVID-19 Pandemic
  Emerging Infectious Diseases, Supplement Issue, December 2022
• Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants co-authored by Fogarty’s Kaiyuan Sun & Cécile Viboud
  BMC Medicine, November 15, 2022
• ACT-Accelerator launches six month plan as world transitions to long-term COVID-19 control
  WHO news, October 28, 2022
• Study Shows Benefits of COVID-19 Vaccines and Boosters
  NIH Director’s Blog, October 18, 2022
• Findings suggest COVID-19 rebound not caused by impaired immune response
  NIH/NIAID news, October 6, 2022
• NIH-funded team develops method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance
  NIH/NIBIB news, September 15, 2022
• Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey, Fogarty grantees Mitermayer Reis and Albert I. Ko co-authors
  PLOS Medicine, September 8, 2022
• SARS-CoV-2 antigen levels linked to patient outcomes
  NIH/NIAID news, August 29, 2022
• WHO releases global COVID-19 vaccination strategy update to reach unprotected
  WHO news, July 22, 2022
• Perspective: Syndemics and clinical science authored by former Fogarty Scholar Emily Mendenhall
  Nature Medicine, July 21, 2022
• Compliance with Health Recommendations and Vaccine Hesitancy During the COVID Pandemic in Nine Countries authored by Fogarty grantee Jennifer Lansford
  Prevention Science, July 20, 2022
• Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020, Fogarty Fellow Sigrid Collier co-author
  PLOS Medicine, July 19, 2022
• Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time
  NIH/NIAID news, July 19, 2022
  
• Small NIH study reveals how immune response triggered by COVID-19 may damage the brain
  NIH/NINDS news, July 5, 2022
• Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations, co-authored by Fogarty’s David J. Spiro and Cécile Viboud
  PLos Pathogens, June 30, 2022
• NIH-funded project offers efficient approach when tracking SARS-CoV-2 variants
  NIH/NIBIB news, June 29, 2022
• Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa, Fogarty grantee Tulio de Oliveira, former Fogarty fellow Sikhulile Moyo,, and former Fogarty trainees Dikeledi Kekana, Jinal N. Bhiman and Simani Gaseitsiwe co-authors
  Nature, June 27, 2022
• Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination, co-authored by Fogarty’s Cécile Viboud
  eLife, June 21, 2022
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis, Fogarty grantees Jean Nachega, Nadia Sam-Agudu, Rhoderick Machekano, and Philip J. Rosenthal lead authors
  Clinical Infectious Diseases, June 8, 2022
  • Related commentary: Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries
    Clinical Infectious Diseases, June 8, 2022
• Food allergy is associated with lower risk of SARS-CoV-2 infection
  NIH/NIAID news, June 1, 2022
• WHO validates 11th vaccine for COVID-19
  WHO news, May 19, 2022
  
• Scientists identify characteristics to better define long COVID
  NIH/NCATS news, May 16, 2022
  
• NIH Licenses COVID-19 Research Tools and Early-Stage Technologies to WHO Program
  HHS news, May 12, 2022
• Unique binding of Delta variant may explain high transmissibility
  NIH news, May 11, 2022
  
• Modeling transmission of SARS-CoV-2 Omicron in China, co-authored by Fogarty’s Kaiyuan Sun
  Nature, May 10, 2022
  
• WHO launches first ever global report on Infection Prevention and Control
  WHO news release, May 6, 2022
  
• Managing Post-Stroke Care During the COVID-19 Pandemic at a Tertiary Care Level Hospital in Peru Fogarty Scholar Jessica Hanae Zafra-Tanaka lead author
  Journal of Stroke and Cerebrovascular Diseases, April 2022
• Updated Guidance for COVID-19 and People with HIV
  from the NIH Office of AIDS Research, February 22, 2022
• WHO prequalifies first monoclonal antibody - tocilizumab – to treat COVID-19 
  WHO news release, February 11, 2022
  
• Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria 
  co-authored by Fogarty grantee Dr. Babafemi Taiwo
  Nature Communications, February 3, 2022
• The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 – September 2021, co-authored by Fogarty's Amanda Perofsky and Dr. Cecile Viboud
  Clinical Infectious Diseases, January 27, 2022
  
• Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19
  NIH news release, January 27, 2022
• Impact of the COVID-19 Pandemic on Chronic Disease Care in India, China, Hong Kong, Korea, and Vietnam, Fogarty grantee Kavita Singh lead author
  Asia Pacific Journal of Public Health, January 24, 2022
• Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries, co-authored by former Fogarty grantee Dr. Jean Nachega
  JAMA Pediatrics, January 19, 2022
  • Related commentary: Global Representation During a Global Pandemic
    JAMA Pediatrics, January 19, 2022
• WHO recommends two new drugs to treat COVID-19
  WHO news release, January 14, 2022
• Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa 
  co-authored by former Fogarty fellow Dr. Sikhulile Moyo
  Nature, January 7, 2022
  

Bioethics News

• COVID-19 vaccine trial ethics once we have efficacious vaccines, co-authored by Fogarty's Dr Joseph Millum
  Science, December 3, 2020
• New COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response
  WHO news, July 22, 2020
  • COVID-19 Law Lab, a joint project of WHO, UNDP, UNAIDS, the O’Neill Institute for National and Global Health Law and Georgetown University
    
• Guidance on COVID-19 human subjects protection
  HHS Office for Human Research Protections (OHRP), April 8, 2020
  

News for Low- and Middle-income Countries (LMICs)

• Association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case-control study co-authored by former Fogarty trainees Glenda Gray and Linda-Gail Bekker, British Journal of Sports Medicine, October 30, 2022
• Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries, Fogarty grantees Jean Nachega, Nadia Sam-Agudu, Mark Siedner, and Philip J. Rosenthal lead authors
  Clinical Infectious Diseases, October 15, 2022
• Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries
  co-authored by former Fogarty grantee Dr. Jean Nachega
  JAMA Pediatrics, January 19, 2022
  • Related commentary: Global Representation During a Global Pandemic
    JAMA Pediatrics, January 19, 2022
• Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
  The Lancet, December 21, 2021
• Perspective: Scaling up COVID-19 vaccination in Africa - Lessons from the HIV pandemic, co-authored by Fogarty grantee Dr Jean B Nachega New England Journal of Medicine, March 31, 2021
• Pragmatic recommendations for the management of hospitalized COVID-19 patients in low- and middle-income countries [Open access]
  Supplement to The American Journal of Tropical Medicine and Hygiene, March 10, 2021
• Contact tracing in the COVID-19 response: Best practices in Africa
  Recorded webinar presented by AFREhealth and Fogarty, October 5, 2020
  
• From easing lockdowns to scaling-up community-based COVID-19 screening, testing, and contact tracing in Africa - shared approaches, innovations, and challenges to minimize morbidity and mortality, featuring Fogarty grantee Dr. Jean Nachega as lead author
  Clinical Infectious Diseases, May 31, 2020
• Mobile health technology for enhancing the COVID-19 response in Africa: A potential game changer?
  The American Journal of Tropical Medicine and Hygiene, May 29, 2020
• COVID-19: Shining the light on Africa, co-authored by Fogarty senior scientist emeritus Dr Joel Breman
  The American Journal of Tropical Medicine and Hygiene, May 5, 2020
• Curriculum for youth: COVID-19! How Can I Protect Myself and Others? available in 15 languages
  Smithsonian Science Education Center, May 2020
• Comment: Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries, co-authored by Fogarty grantee
  The Lancet Global Health, April 28, 2020
• The potential impact of health service disruptions on the burden of malaria: A modelling analysis for countries in sub-Saharan Africa
  WHO, April 23, 2020
• Strategies combining self-isolation, moderate physical distancing and shielding likely most effective COVID-19 response for African countries
  London School of Hygiene and Tropical Medicine news, April 21, 2020
• Correspondence: Global rheumatology in the time of COVID-19, co-authored by former Fogarty Fellows Drs. Laura B Lewandowski and Evelyn Hsieh
  The Lancet Rheumatology, April 6, 2020
• Comment: Global coalition to accelerate COVID-19 clinical research in resource-limited settings
  The Lancet, April 2, 2020
• Gene studies grow in Nigeria [Audio]: Local researchers trained through H3Africa help trace source of first confirmed case of coronavirus in Nigeria
  The World, Friday, March 13, 2020
• Children's picture book: My Hero is You, How kids can fight COVID-19! available in more than 80 languages
  Inter-Agency Standing Committee (IASC), March 2020
• Viewpoint: Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China [Free access] featuring Fogarty trainee Dr Zunyou Wu as lead author
  JAMA, February 24, 2020
• Coronavirus and low-income countries: Ready to respond?
  Center for Global Development blog post, January 31, 2020